Home › Funds › Saratoga Research & Investment Management › NVS
Saratoga Research & Investment Management position in NVS
NOVARTIS AG · Health Care
Saratoga Research & Investment Management reported holding 1,490 shares of NVS (NOVARTIS AG) in its Q3 2026 13F filing — a position valued at US$212K, representing 0.01% of its reported portfolio and ranking #44 among its reported holdings. Saratoga Research & Investment Management has disclosed NVS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR
How Saratoga Research & Investment Management's NVS position evolved
Saratoga Research & Investment Management first disclosed a stake in NVS in Q4 2025 at 1,490 shares (US$205K). The position peaked in Q2 2026 at 1,490 shares, worth US$234K. Across 4 filings, Saratoga Research & Investment Management held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,490 shares valued at US$212K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.49K | $205.43K | New |
| Q1 2026 | 1.49K | $227.60K | Hold |
| Q2 2026 | 1.49K | $233.51K | Hold |
| Q3 2026 | 1.49K | $212.43K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (NOVARTIS AG) is a Health Care company. 24 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.43B), PRIMECAP MANAGEMENT CO/CA/ (US$1.03B), LOOMIS SAYLES & CO L P (US$821.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 15.52M sh · $2.43B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $1.03B · Q2 2026
- LOOMIS SAYLES & CO L P 5.24M sh · $821.10M · Q2 2026
- NATIXIS ADVISORS, LLC 2.39M sh · $374.02M · Q2 2026
- GQG Partners LLC 2.15M sh · $337.13M · Q2 2026
- Cullen Capital Management, LLC 2.03M sh · $318.62M · Q2 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.90M sh · $300.11M · Q2 2026
More on Saratoga Research & Investment Management
FAQ
How long has Saratoga Research & Investment Management held NVS?
Saratoga Research & Investment Management has disclosed NVS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Saratoga Research & Investment Management's current position in NVS?
As of Q3 2026, Saratoga Research & Investment Management holds 1.49K shares of NVS (NOVARTIS AG), valued at $212.43K, representing 0.01% of its reported portfolio and ranking #44.
Has Saratoga Research & Investment Management been buying or selling NVS?
In the latest 13F filing (Q3 2026), Saratoga Research & Investment Management held unchanged its position in NVS. The position peaked in Q2 2026 at 1.49K shares.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.